Statements (15)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:acquiredBy |
gptkb:Grifols
|
gptkbp:acquisitionYear |
2011
|
gptkbp:founded |
2005
|
gptkbp:headquarters_location |
gptkb:Research_Triangle_Park,_North_Carolina,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Talecris Biotherapeutics
|
gptkbp:industry |
biopharmaceuticals
|
gptkbp:numberOfEmployees |
over 4,700 (at time of acquisition)
|
gptkbp:parentCompany |
gptkb:Grifols
|
gptkbp:products |
plasma-derived therapies
|
gptkbp:publiclyTraded |
yes
|
gptkbp:stockSymbol |
gptkb:TLCR
|
gptkbp:website |
www.talecris.com
|
gptkbp:bfsParent |
gptkb:CSL_Limited
|
gptkbp:bfsLayer |
6
|